Novo Nordisk Shares Surge on New Obesity Drug Results

Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump

Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs.

CNBC - 52m

Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.

The New York Times - 1h

Will This New GLP-1 Drug be More Powerful Than Ozempic?

Investors seek answers on Novo Nordisk’s next-gen obesity drug, CagriSema.

Inc. - 1d

Alphabet shares sink after cloud growth stalls and spending surges

Google vows to spend $75bn this year on data centres to meet rising demand from AI

Financial Times - 3h

Novo Nordisk sales beat estimates, but the story wasn’t Ozempic

Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t its wildly popular weight-loss drugs.

MarketWatch - 8h

Novo Nordisk Foundation Will Not Fill Funding Gaps

Global health experts have questioned how philanthropies could mitigate Trump’s freeze on foreign health aid.

Inc. - 1d

Americans split on using weight loss drugs to treat obesity: Survey

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, according to a survey published Friday. The new Associated Press (AP)-NORC ...

The Hill - 4d

Obesity-drug maker Metsera posts largest gain as IPOs defy market swoon

Oil company Natural Resources and medical-device maker Beta Bionics shrug off a down market to gain in their trading debuts.

MarketWatch - 4d

US regulators approve new non-opioid drug to treat acute pain

Oral drug from Vertex, branded as Journavx, represents alternative to addictive opioids that have fueled US crisis . The US Food and Drug Administration approved a new drug to treat acute pain, the ...

The Guardian - 5d

The FDA’s new, same-old food labels demand better obesity solutions

All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

The Hill - 6d

Shares of LVMH drop 5% as full-year results throw doubt on broad luxury recovery

LVMH shares dropped as slightly better-than-expected full-year results from the world's largest luxury company threw doubt over a broader sector recovery.

CNBC - Jan. 29

ASML shares jump 10% as surge in orders defies fears of DeepSeek hitting AI chip demand

Dutch semiconductor equipment maker ASML on Wednesday reported better-than-expected net sales and profit results for the fourth quarter.

CNBC - Jan. 29

FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.

CNBC - Jan. 28

Delta Air Lines Just Got a Lucky Break, and the Result Was Some Very Good News

Accolades matter in business. Luck does, too.

Inc. - Jan. 26

Novo Nordisk shares pop on early-stage weight loss drug trial results

The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

CNBC - Jan. 24

Ozempic maker’s stock surges. A trial of a new Novo Nordisk drug shows promise.

Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%.

MarketWatch - Jan. 24

Oracle Shares Surge as Trump Reveals $500 Billion AI Plan

Oracle saw massive growth today.

Inc. - Jan. 22

Surging Drug Violence in Colombia Dooms President's 'Total Peace' Plan

The clashes between rival guerrilla groups have left 80 dead as Colombia braces for cutbacks in U.S. foreign aid under President Trump.

The Wall Street Journal - Jan. 22

Adidas Shares Jump After Preliminary Results Beat Expectations

The sporting-goods company surpassed its own profit expectations amid fierce competition in the sector and as its biggest rival, Nike, continues to pursue a brand revamp strategy.

The Wall Street Journal - Jan. 22

TGL golf results, takeaways: Justin Thomas, Patrick Cantlay's Atlanta team beats Rickie Fowler's New York side

The third week of TGL featured the most competitive match yet

CBS Sports - Jan. 22

Netflix shares soar as company reports surging revenue, tops 300 million subscribers

The fourth quarter was the last for which Netflix will report quarterly paid subscriber counts.

CNBC - Jan. 21

Netflix shares soar as company reports surging revenue, tops 300 million subscribers

Shares of Netflix soared more than 13% Tuesday after the company posted fourth-quarter results that beat on the top and bottom lines.

NBC News - Jan. 21

The war on drugs needs a new tactic: shame

Liberal reformers have been too hesitant to spell out the negative consequences for others

Financial Times - Jan. 21

US share of global foreign direct investment surges to record

‘Exceptionalism’ of world’s biggest economy expected to continue as strong domestic demand drives inward flows

Financial Times - Jan. 21

At Least 80 Dead in Colombia Amid a New Surge of Violence

Clashes between armed groups in Colombia have led to some of the worst violence in the country in years.

The New York Times - Jan. 20

Obesity drugs Ozempic and Wegovy included in US price-cut talks

Novo Nordisk shares hit as government adds blockbuster weight-loss treatments to new round of negotiations

Financial Times - Jan. 17

Biden sets pardons and commutations record with new clemency for nonviolent drug offenders

The president said that with Friday's action he has "now issued more individual pardons and commutations than any president in U.S. history."

NBC News - Jan. 17

Suess Microtec Shares Soar After Forecast-Beating Results

Shares in the German chip-equipment supplier surged after it reported full-year results that exceeded guidance, boosted by AI’s growing momentum.

The Wall Street Journal - Jan. 17

Goldman Sachs shares rise after topping estimates on strong trading results

Goldman's fourth-quarter results will give investors a preview of what to expect this year, as investment banking and trading fees are both expected to rise.

CNBC - Jan. 15

Obesity needs new definition beyond BMI, says global report

There is a risk too many people are being diagnosed as obese, with weight-loss drugs in high demand.

BBC News - Jan. 15

Obesity wouldn't be solely defined by BMI under global experts' new plan

A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial body mass index and hoping to better identify people who need treatment ...

NBC News - Jan. 15

AI set to fuel surge in new US gas power plants

Climate targets in peril as Big Tech turns to fossil fuels to feed energy demand

Financial Times - Jan. 13

New York City’s Economy Surged in 2024. A Trump Shake-Up Looms.

The city has made up much of the ground it lost amid the coronavirus pandemic. Donald J. Trump’s return to the White House could upend that recovery.

The New York Times - Jan. 9

Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact

At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss ...

MarketWatch - Jan. 8

Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally. Pills that prevent Alzheimer’s disease or blunt its effects are on the horizon, ...

The Guardian - Jan. 8